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Investigating the Association Between Anti-Brucella Titers and the
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NASRALLAH,2 SAMIR ALAM2
From 1Department of Family Medicine, American University of Beirut Medical Center; 2Department of Internal
Medicine, American University of Beirut Medical Center; 3Faculty of Health Sciences, American University of Beirut,
Beirut, Lebanon
MUSHARRAFIEH ET AL.: Investigating the Association Between Anti-Brucella Titers and the Development of
Coronary Artery Disease in Middle-East. Background: Several studies have suggested an association between certain
infectious agents and coronary artery disease (CAD). A possible role for brucella in contributing to cardiovascular
disease through its ability to produce a chronic inflammatory state was hypothesized. In this study, brucella was
evaluated for its possible pathogenic role in significant occlusive coronary artery disease through testing for the
presence of positive brucella antibody titers. Methods and Results: Patients referred for coronary angiography at the
American University of Beirut Medical Center between January 2005 and February 2009 were tested for C-reactive
protein (CRP) quantitative level and the presence of brucella antibody titers using ELISA. All participants were asked
to fill a questioner relevant to demographics, risk factors for CAD, and presence of comorbidities. Results: 424
subjects were categorized into two groups; those with greater than 75% stenosis in at least one coronary artery and
those with normal or less than 75% stenosis. Among patients with positive anti-brucella titers, 70.6% had CAD while
among patients with negative anti-brucella titers 74.9% had CAD (P=0.514). In patients with elevated CRP level
(≥3 mg/L), 14.9% had positive titer for brucella, whereas in those with low CRP level (<3 mg/L), 5.8% had positive
titers for brucella (P=0.016). Conclusions: The findings failed to show an association between anti-brucella titers and
the development of significant CAD despite the presence of a significant correlation between brucella antibody
positivity and elevated CRP. Further studies are needed to explore the role of this infectious agent with other known
cardiac risk factors. (J HK Coll Cardiol 2015;23:68-74)
Brucella, Coronary artery disease, C-reactive protein, Inflammation
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Introduction
Coronary artery disease (CAD) continues to be
the leading cause of morbidity and mortality in both
industrialized and developing countries despite advances
in prevention, detection, and treatment.1 Hyperlipidemia,
hypertension, smoking, diabetes, family history, obesity
and inactivity are well-documented risk factors for CAD.2
However, in approximately half of the patients with
CAD, the above mentioned risk factors are not present
and thus the search for other factors is warranted.3
Previous studies have suggested a possible role for
infectious agents in the pathogenesis of CAD. 4,5
Chlamydia pneumonia, 6 Helicobacter pylori, 7
and Porphyromonas gingivalis, 8 cytomegalovirus, 9
herpes simplex virus,10 and hepatitis A virus11 were all
evaluated.
Brucellosis is a debilitating disease caused by
Brucella spp. that can affect different organs and may if
inappropriately treated lead to a chronic illness. Both
the acute and chronic manifestations of brucellosis are
due to inflammatory phenomena. There is current
evidence that Brucella spp., can infect and survive within
the endothelial cells, and can induce a pro-inflammatory
response that might be involved in the vascular
manifestations of brucellosis. The release of adhesion
molecules and pro-inflammatory chemochines during a
brucella infection plays an important role in the
activation of the endothelial system. This activation may
be responsible for the pathogenesis of the damage in
the vascular system. 12 The link between brucella
infection and atherogenic lipid profile coupled with
endothelial dysfunction may be a contributing factor in
the development of coronary artery disease.13
Brucella is known to be endemic in the Middle
East region with a reported incidence between 40-69
per 100,000 population in countries like Saudi Arabia,
Kuwait and Jordan.14
In Lebanon, a study conducted by Araj et al
included 597 persons with high risk occupations found
that the overall seroprevalence of brucella titers ranged
from 26-61%.15 Data from the Lebanese Ministry of
Public Health reveals an annual average of 220 brucella
cases reported over the past 14 years.16 In a recent study
from Greece acute brucellosis was associated with a shift
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of serum lipids, lipoproteins, and associated enzymes
toward a more atherogenic lipid profile, which is not
fully restored 4 months after treatment.17 Along the same
token, abnormal flow-mediated dilatation (FMD)
measurement as reflection of endothelial function and
thus the first stage of atherogenesis, might be a marker
of arterial dysfunction, increased cardiovascular risk and
atherosclerosis.18
The aim of the present study is to investigate the
presence of any association between brucella serology
positivity and the occurrence of significant coronary
artery disease.

Materials and Methods
Study Population
Following Institutional Review Board approval,
all patients admitted to the American University of Beirut
Medical Center and referred for coronary angiography
between January 2005 and February 2009 were
approached for recruitment in the study. Written
informed consent was obtained from eligible patients
for drawing and using blood samples for scientific
research after explaining the aim of the study and nature
of the procedure.
Based on the diagnostic findings of the coronary
angiography, patients enrolled were categorized into two
groups. The first group included patients with normal
coronary arteries and those with less than 75% luminal
stenosis by angiography, the second group included
patients with 75% luminal stenosis or more in at least
one coronary artery. All those who have experienced
myocardial infarction within the previous 6 months,
valvular heart disease, or non-atherosclerotic
cardiomyopathy were excluded.

Study Design
Atherosclerosis Risk Factors
Medical records of enrolled patients were
reviewed for demographics (age and gender), the
presence of known risk factors for CAD including family
history, diabetes mellitus (DM), hypertension (HTN),
hypercholesterolemia (HCL), obesity, smoking, and
dietary habits. Medical records were also reviewed for
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prior history of brucellosis and intake of medications
including statins and antibiotics within the previous three
months.

models were used to assess the independent associations
of various risk factors to CAD.

Results

Laboratory Testing
Serum samples obtained from all study subjects
were frozen at -70 degrees centigrade, and aliquots were
thawed when needed for testing. All samples obtained
were tested for brucella antibody titers using ELISA to
detect brucella-specific antibodies (Anti IgG-C3d,
Bioclone/Ortho-clinical Diagnostic, inc). This test was
previously reported to have sensitivity, specificity,
positive and negative predictive values of ≥97%, ≥98%,
≥85%, and ≥97%, respectively, according to the
manufacturer's instructions. An antibody titer of 1:20 or
greater was considered to be positive. Quantitative
ELISA was used to determine serum C-reactive protein
(CRP) (CRP-kit, Roche/Hitachi, Mannheim, Germany)
level. A set of CRP standards was used to plot a standard
curve of absorbance versus CRP concentration from
which the CRP concentrations in the unknown can be
calculated.

Statistical Analysis
Statistical analysis was carried out with the
Statistical Package for the Social Sciences (SPSS)
version 13 (SPSS Inc., Chicago, Illinois, USA).
Categorical data were analyzed by the chi squared test
(Fisher's exact test for small samples), with all tests
double-sided. Analyses of CRP serum level in relation
to CAD and other factors were made by the unpaired
t-test between different groups as a continuous variable
and further adjusted using partial correlation
investigation. Estimated Pearson correlation value (r)
was used to indicate the strength of the relationship.
The covariates considered included age, male sex,
cigarette smoking, diabetes, HCL, HTN, and family
history. Results for normally distributed continuous
variables are expressed as mean ± SD. A probability
value of P<0.05 was considered significant.
Categorized data were analyzed by the chi squared
test. Differences in means of continuous variables
between groups were compared by means of the
independent samples t-test and ANOVA if more than 2
groups were assessed. Logistic and linear regression
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A total of 424 patients were included in the study.
Of these, 15.6% had taken antibiotics during the three
months prior to enrollment. Among the study group
57.3% were smokers, 35.1% consumed alcohol, 63.2%
were sedentary, 28.5% had DM, 55.6% had HCL, and
42.2% were on statin therapy at the time of enrollment
and 12.6% had positive anti-brucella titers (Table 1).

Table 1. Baseline characteristics of the participants
Number (percentage)
Gender
Male
Female
Smoking history
Yes
Physical activity
None
Minimal (2-3 days/week)
Moderate (3-4 days/week)
Vigorous (>5 days/week)
History of diabetes
Yes
Hyperlipidemia
Yes
Statin
Yes
C-reactive protein
<3 mg/L
>3 mg/L
Brucella
Positive
Negative
Coronary artery disease
Yes
No
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306 (72.2%)
118 (27.8%)
243 (57.3%)
268 (63.2%)
74 (17.5%)
30 (7.0%)
52 (12.3%)
121 (28.5%)
236 (55.6%)
179 (42.2%)
110 (25.9%)
314 (74.1%)
54 (12.6%)
370 (87.4%)
316 (74.5%)
108 (25.5%)
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Among patients with positive anti-brucella titer
70.6% had significant CAD (≥75% luminal stenosis),
compared with 74.9% among patients with negative antibrucella titer (P=0.514) (Figure 1).
In patients with elevated CRP level ≥3 mg/L,
14.9% had positive anti-brucella titers, whereas in those
with low CRP level <3 mg/L, 5.8% had positive antibrucella titers (P=0.016) (Figure 2).

3.40). Meanwhile patients with DM had a two-fold
increased risk (OR=2.217, 95% CI: 1.26-3.89) and
those on statins had 2.8-fold increased risk than patients
not on statin therapy (OR=2.865, 95% CI: 1.73-4.71),
whereas patient with dyslipidemia had 2.4 fold increased
risk (OR=2.421, 95% CI: 1.67-3.86) (Table 3).

Discussion

Occlusive Coronary Artery Disease
Chi-square testing was performed to compare
presence of occlusive CAD with other risk factors. Those
found to be significantly associated with occlusive CAD
were male gender (P=0.004), smoking (P=0.001),
hypercholesterolemia (P=0.008), diabetes (P=0.010),
statin therapy (P=0.001), CRP >3 (P=0.010) and statin
therapy with a CRP level ≥3 (P=0.002). All other
variables were not found to be statistically significant
(Table 2).
Upon performing binary logistic regression, the
variables found to be predictors of occlusive CAD were
male gender (P=0.003), DM (P=0.005), HCT (P=0.008)
and statin intake (P<0.001). Males were twice as likely
to develop occlusive CAD as compared to females (odd
ratio (OR)=2.090, 95% confidence interval (CI): 1.28-

CPR: C-reactive protein

CAD: coronary artery disease

Figure 1. For patients positive for brucella 70.6% had CAD,
and patients with negative brucella titers 74.9% had CAD
(P=0.514).
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The current study has shown clearly
the significant association of occlusive CAD and
traditional risk factors including DM, smoking,
hypercholesterolemia, high CRP and statin therapy. It
has failed to find any association between occlusive
CAD, alcohol intake, physical activity, recent antibiotic
therapy and a positive brucella serology.
Few studies addressed the role of brucella
infection as a risk factor for CAD. We found that positive
anti-brucella titers did not weigh as a risk factor for
significant disease conventional occlusive disease.
Previous studies have postulated a link between certain
microbial agents and cardiovascular events. Various
methods, including immune serology and nucleic acid
techniques, were utilized to assess the existence and

Figure 2. Patients with elevated CRP (≥3 mg/L) 14.9% had
positive titers for brucella whereas patients with low CRP
(<3 mg/L) 5.8% had positive brucella titers (P=0.016).
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significance of such relation. Brucella, an intracellular
organism that can produce a persistent infection and
induce long-lasting effects on the host was mentioned
in previous reports to be a possible candid pathogen. In
a recent study, Togan et al suggested that the abnormal
FMD observed in brucella patients might be an indicator
of arterial dysfunction, increased cardiovascular risk and
possibility of atherosclerosis. 19 The findings of the
present study did not corroborate such an association.
Previous reports have suggested an association between

serum antibody titers against Chlamydia and
Mycoplasma with unstable angina or myocardial
infarction. However, these studies were in the acute
phase and not when patients were completely
asymptomatic like in those evaluated in the current
study.20
A recent review suggested that elevated levels of
CRP, was a predictor of acute coronary syndromes.21
In a study of 5248 subjects, there was a correlation
between CRP levels (>10 mg/L) and the risk of

Table 2. Association between CAD and other variables
Variable

CAD
Yes (n=316)

Gender
Male
Female
Smoking
Hyperlipidemia
Statin therapy
Statin therapy with elevated CRP
Diabetes mellitus
CRP >3 mg/L
Drinking alcohol
Antibiotics
Physical activity
None/Minimal
>Moderate
Brucella titer >1:20

P-value
No (n=108)
0.004*

240 (75.9%)
76 (24.1%)
196 (62.0%)
194 (61.4%)
153 (48.4%)
107 (33.8%)
101 (31.9%)
231 (73.1%)
112 (35.4%)
48 (15.1%)

66 (61.1%)
42 (38.9%)
47 (43.1%)
42 (38.8%)
26 (24.0%)
18 (16.6%)
20 (18.5%)
72 (66.6%)
38 (35.1%)
17 (15.7%)

256 (81.0%)
60 (19.0%)
38 (12.0%)

86 (79.6%)
22 (20.4%)
16 (14.8%)

0.001*
0.008*
0.000*
0.002*
0.010*
0.010*
0.745
0.673
0.565

0.455

*statistically significant
CAD: coronary artery disease; CPR: C-reactive protein

Table 3. Logistic regression for CAD
Variable
Gender (Male)
Diabetes mellitus
Statin therapy
Hyperlipidemia

Odd ratio
2.090
2.217
2.865
2.421

95% CI for odd ratio
1.28
1.26
1.73
1.67

3.40
3.89
4.71
3.86

P-value
0.003
0.005
0.000
0.008

CAD: coronary artery disease; CI: confidence interval
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cardiovascular events as well as all-cause mortality.22
Patients with high CRP were more likely to have more
severe CAD disease than those with lower CRP levels
(63.2% had at least one vessel disease greater than 75%
vs. 44.3% and 45.8%) (P=0.001) This is consistent with
recent reports showing a significant correlation between
serum CRP levels and severity of CAD as assessed by
angiographic Gensini score. 23 Our results are in
agreement with these reports and confirm that elevated
levels of CRP are associated with at least one vessel
disease with stenosis of greater than 75%, unrelated to
brucella infection. Another report suggested that
Brucella species can infect and survive within
endothelial cells, and can induce a pro-inflammatory
response that might be involved in the vascular
manifestations of brucellosis.24 Despite the findings in
our report that patients with elevated CRP (≥3) were
more likely to have positive anti-brucella titers than
those with low CRP (14.9% vs. 5.8%), it was difficult
to prove the presence of any significant association
as a contributory factor to occlusive CAD. Our
negative findings do not negate the possible role of
brucella as a preparative trigger in CAD. It has been
shown that the response of the host to brucella
infection and inflammation leads to an increase in
oxidized lipids in the serum, and brings about LDL
oxidation in vivo. Oxidative modification of LDL is one
of the important events leading to the development of
atherosclerosis.13 Although the degree of inflammation
induced by brucella seems to be lower than in infections
caused by other organism, the chronic nature of
the infection argues in favor of inflammation as a
cause of tissue damage. This is due to a low degree of
stimulation but incessant inflammatory tissue damaging
response.24
Our results cannot evaluate the combined effect
of various triggers or risk factors in the pathogenesis of
occlusive disease. A weak trigger of inflammation as in
a chronic brucella infection in a high risk patient may
lead to a different CAD outcome when compared to a
more potent trigger in a low risk patient.
It is reasonable to think that the same trigger of
inflammation may lead to different outcomes in patients
with different other risks for CAD. Ozbudak et al have
alluded to this through a study that showed a synergistic
effect of infection and cholesterol rich diet on
73

atherosclerosis in pulmonary arteries. The authors
concluded that antibiotics and anti-inflammatory agents
could be useful in prevention.25
Some published data have suggested that the
aggregate effect of co-infection with multiple organisms
rather than one organism may be responsible for the
atherosclerotic role. This has been eluded to as the
"infectious burden" or "pathogen burden".17,26 In one
study, over 75% of CAD patients had been exposed to
at least three of five pathogens tested, suggesting a
possible link between increased pathogen burden and
the risk of CAD irrespective of traditional risk factors.27
Thus, the contribution of infectious organisms to
atherosclerosis pathogenesis is likely to involve
simultaneous direct and indirect mechanisms involving
multiple organisms.

Limitation
The authors recognize the selection bias inherent
in enrolling subjects from a patient population that is
undergoing an invasive cardiovascular procedure. The
results obtained may not be necessarily applicable to
the population as a whole. Another important limitation
is attempting to categorize the study population into
those with and without significant occlusive disease
(more than 75% stenosis) irrespective of the presence
of lumen-limiting CAD or not. In addition, other risk
factors assessment for CAD may not be comprehensive,
in that information on hypertension, with or without antihypertensive therapy is lacking.

Conclusion
The current study failed to show an association
between positive brucella serology and the development
of significant occlusive CAD, despite the presence of a
significant correlation between brucella antibody
positivity and elevated CRP.
Further studies are needed to explore any
relationship between brucella infection and CAD
including acute versus chronic infection, co-infection
with other pathogens, and the interaction with other
known risk factors.
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